ArticleFrontiers in immunology2022

LATPS, a novel prognostic signature based on tumor microenvironment of lung adenocarcinoma to better predict survival and immunotherapy response.

Jihong Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.